Lupin 2024

generic drug manufacturers

Suit accuses six generic drug makers of price fixing

Suit accuses six generic drug makers of price fixing

HARTFORD, Conn. — Twenty states have accused six generic drug manufacturers of price ­fixing. The states’ attorneys general also said their lawsuit, filed in federal court here, may be just the start of a much broader legal action. The suit charges that the drug makers, led by New Jersey-based Heritage Pharmaceuticals, conspired to artificially elevate

FDA pushes back generic drug labeling rule

FDA pushes back generic drug labeling rule

WASHINGTON — The Food and Drug Administration is again postponing the release of a final rule that would change generic drug labeling requirements. In a Federal Register notice this week, the FDA indicated that it aims to implement the final rule in April 2017, though many industry stakeholders had expected the agency to do so

PP_1170x120_10-25-21